Search research articles
Contact Us
Filters
Showing results (81-90 of 437) with videos related to
Page
of 44
Sort By:
Cancer Chemotherapy and Pharmacology
|
August 11, 2012
A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors
Hiroshi Nokihara, Noboru Yamamoto, Yasuhide Yamada, et al.
The Journal of Dermatology
|
April 5, 2019
Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab
Yusuke Muto, Shigehisa Kitano, Arata Tsutsumida, et al.
Japanese Journal of Clinical Oncology
|
July 27, 2007
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung
Yutaka Fujiwara, Ikuo Sekine, Koji Tsuta, et al.
Immunotherapy
|
October 3, 2015
Tremelimumab-associated tumor regression following after initial progression: two case reports
Akihiko Shimomura, Yutaka Fujiwara, Shunsuke Kondo, et al.
BMC Research Notes
|
March 27, 2026
Tolerability and safety of magrolimab (ONO-7913) in Japanese patients with advanced or metastatic solid tumors: a phase 1, open-label, uncontrolled, dose-escalation study
Takafumi Koyama, Toshio Shimizu, Shunsuke Kondo, et al.
International Journal of Clinical Oncology
|
June 30, 2026
A phase 1 dose-finding and pharmacokinetic study of acasunlimab alone or in combination with pembrolizumab in Japanese patients with advanced or metastatic solid tumors
Noboru Yamamoto, Gaurav Bajaj, Homer C Adams, et al.
Journal of Physical Therapy Science
|
November 9, 2016
Effect of mental practice using inverse video of the unaffected upper limb in a subject with chronic hemiparesis after stroke
Naoki Iso, Shirou Ooso, Noboru Yamamoto, et al.
Thoracic Cancer
|
June 30, 2022
Erlotinib with or without bevacizumab as a first-line therapy for patients with advanced nonsquamous epidermal growth factor receptor-positive non-small cell lung cancer: Exploratory subgroup analyses from the phase II JO25567 study
Yukio Hosomi, Takashi Seto, Makoto Nishio, et al.
Cancer Science
|
November 9, 2010
Innovator and generic cisplatin formulations: comparison of renal toxicity
Ikuo Sekine, Kaoru Kubota, Yosuke Tamura, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
Delta9-tetrahydrocannabinol immunochemical studies: haptens, monoclonal antibodies, and a convenient synthesis of radiolabeled delta9-tetrahydrocannabinol
Longwu Qi, Noboru Yamamoto, Michael M Meijler, et al.
Page
of 44
Search research articles
Search
Showing results (81-90 of 437) with videos related to
Sort By:
Page
of 44
Cancer Chemotherapy and Pharmacology
|
August 11, 2012
A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors
Hiroshi Nokihara, Noboru Yamamoto, Yasuhide Yamada, et al.
The Journal of Dermatology
|
April 5, 2019
Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab
Yusuke Muto, Shigehisa Kitano, Arata Tsutsumida, et al.
Japanese Journal of Clinical Oncology
|
July 27, 2007
Effect of platinum combined with irinotecan or paclitaxel against large cell neuroendocrine carcinoma of the lung
Yutaka Fujiwara, Ikuo Sekine, Koji Tsuta, et al.
Immunotherapy
|
October 3, 2015
Tremelimumab-associated tumor regression following after initial progression: two case reports
Akihiko Shimomura, Yutaka Fujiwara, Shunsuke Kondo, et al.
BMC Research Notes
|
March 27, 2026
Tolerability and safety of magrolimab (ONO-7913) in Japanese patients with advanced or metastatic solid tumors: a phase 1, open-label, uncontrolled, dose-escalation study
Takafumi Koyama, Toshio Shimizu, Shunsuke Kondo, et al.
International Journal of Clinical Oncology
|
June 30, 2026
A phase 1 dose-finding and pharmacokinetic study of acasunlimab alone or in combination with pembrolizumab in Japanese patients with advanced or metastatic solid tumors
Noboru Yamamoto, Gaurav Bajaj, Homer C Adams, et al.
Journal of Physical Therapy Science
|
November 9, 2016
Effect of mental practice using inverse video of the unaffected upper limb in a subject with chronic hemiparesis after stroke
Naoki Iso, Shirou Ooso, Noboru Yamamoto, et al.
Thoracic Cancer
|
June 30, 2022
Erlotinib with or without bevacizumab as a first-line therapy for patients with advanced nonsquamous epidermal growth factor receptor-positive non-small cell lung cancer: Exploratory subgroup analyses from the phase II JO25567 study
Yukio Hosomi, Takashi Seto, Makoto Nishio, et al.
Cancer Science
|
November 9, 2010
Innovator and generic cisplatin formulations: comparison of renal toxicity
Ikuo Sekine, Kaoru Kubota, Yosuke Tamura, et al.
Journal of Medicinal Chemistry
|
November 11, 2005
Delta9-tetrahydrocannabinol immunochemical studies: haptens, monoclonal antibodies, and a convenient synthesis of radiolabeled delta9-tetrahydrocannabinol
Longwu Qi, Noboru Yamamoto, Michael M Meijler, et al.
Page
of 44